Ironwood Pharmaceuticals

Ironwood Pharmaceuticals

Yahoo Finance • 17 days ago

Top profitable small caps trading at bargain P/E multiples during Q2 earnings

[Stock market activity shows price changes and trading movements in real time] FabrikaCr As the market moves through second-quarter earnings season, investors are paying close attention to small-cap stocks that combine solid profitability... Full story

Yahoo Finance • 2 months ago

These small-cap healthcare stocks pair revenue growth with attractive valuations

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images Healthcare stocks have remained in focus as investors look for companies that can deliver strong operational growth... Full story

Yahoo Finance • 2 months ago

Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSK

The targeted oncology sector is shifting after GSK (GSK [https://seekingalpha.com/symbol/GSK]) decided to buy [https://seekingalpha.com/news/4601644-gsk-to-buy-nuvalent-for-106b] Nuvalent (NUVL [https://seekingalpha.com/symbol/NUVL]) for $... Full story

Yahoo Finance • 2 months ago

Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess?

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is one of the most undervalued stocks to invest in. TheFly reported on May 27 that IRWD reported that the U.S.... Full story

Yahoo Finance • 4 months ago

Ironwood (IRWD) is One of the Most Attractive Small-Cap Drug Manufacturers, Here is Why

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) is one of the 7 best small-cap drug manufacturing stocks to buy according to hedge funds. On February 26, Citizens analyst Jason Butler maintained an Outperform rating on Ironwood Pharmaceutical... Full story

Yahoo Finance • 5 months ago

Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential

Sarissa Capital Management established a new position in Biohaven Ltd.(NYSE:BHVN) during the fourth quarter, acquiring 513,184 shares worth $5.79 million at quarter’s end, according to a February 17, 2026, SEC filing. What happened Accor... Full story

Yahoo Finance • 5 months ago

Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility

[Black Bull and Bear] peterschreiber.media/iStock via Getty Images Small-cap outperformance has narrowed over the last couple of weeks as investor caution increased, with volatility and geopolitical risk weighing on risk appetite and narr... Full story

Yahoo Finance • 6 months ago

Ironwood Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary

Ironwood Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Execution and Performance Drivers Delivered 11% LINZESS prescription demand growth in 2025, maintaining a 45% market share despite net price erosion from Medic... Full story

Yahoo Finance • 6 months ago

Ironwood (IRWD) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Feb. 25, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Tom McCourt Chief Medical Officer — Michael Shetzline Chief Financial Officer — Greg Martini Chief Commercial Offi... Full story

Yahoo Finance • 6 months ago

Craig-Hallum Bullish on Ironwood Pharmaceuticals (IRWD), Keeps Buy Rating

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) is one of the cheap hot stocks to invest in right now. On January 5, Craig-Hallum upgraded Ironwood to Buy from Hold and increased the price target to $5.70 from $3.80. On the same day, Citizens... Full story

Yahoo Finance • 6 months ago

Cheap high flyer healthcare stocks - high momentum and low valuation

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As earnings season ramps up and geopolitical tensions keep affecting the markets, below is a list of the top 10 heal... Full story

Yahoo Finance • 8 months ago

Ironwood (IRWD) Skyrockets 23% as Govt Price for Linzess Falls Within Expectations

We recently published 10 Small Stocks with Mighty Gains. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is one of the top-performing stocks on Wednesday. Ironwood Pharmaceuticals soared by 23.32 percent on Wednesday to end at $3.86 apiece a... Full story

Yahoo Finance • 9 months ago

Ironwood surges after Q3 beat; raised outlook for AbbVie-partnered Linzess

[$10 Banknote Stacking, Green Up Arrow Rise] spawns Shares of Ironwood Pharmaceuticals (IRWD [https://seekingalpha.com/symbol/IRWD]) climbed ~34% on Monday after the company well exceeded Street forecasts with its Q3 2025 financials and h... Full story

Yahoo Finance • 12 months ago

Wondering what's happening in today's after-hours session?

Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER CHANGE COMMENT DHAI [https://www.chartmill.com/stock/quote/DHAI/profile... Full story

Yahoo Finance • last year

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Reports Strong Q2 2025 Earnings with 37.5% Revenue Beat and 250% EPS Surge

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD [https://www.chartmill.com/stock/quote/IRWD]) reported its second-quarter 2025 results, delivering a significant earnings beat driven by strong performance of its flagship product LINZESS and progr... Full story

Yahoo Finance • last year

Ironwood Pharmaceuticals appoints KPMG as new auditor, dismisses EY

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) announced that its Audit Committee has dismissed Ernst & Young LLP (EY) as its independent registered public accounting firm. The decision was made on July 3 after the committee solicited and re... Full story

Yahoo Finance • last year

Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday?

We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) stands against other stocks that fall behind amid market optimism... Full story

Yahoo Finance • 3 years ago

Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance

– Expects high-single digit percentage LINZESS® EUTRx prescription demand growth in 2024 – – Expects 2024 adjusted EBITDA of greater than $150 million – BOSTON, January 08, 2024--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: I... Full story

Yahoo Finance • 3 years ago

Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio

BOSTON, December 12, 2023--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. ("Ironwood") (Nasdaq: IRWD), a GI-focused healthcare company, today announced the successful completion of the squeeze-out merger under Swiss law (the "Squeeze-Out... Full story

Yahoo Finance • 4 years ago

15 Small Innovative Companies According to the Media

In this piece, we will take a look at the fifteen small innovative companies according to the media. For more small and innovative companies, head on over to 5 Small Innovative Companies According to the Media. Innovation is the bedrock o... Full story